Skip to main content
PepStack
Blutwerte · Marker

Harnstoff

BUN · Blood Urea Nitrogen · Urea · Harnstoff-N

Nierenwerte
Einheit:
mmol/L
Abbreviation
BUN / Urea

Blood urea nitrogen (BUN) measures the concentration of urea in the blood, reflecting protein metabolism and renal function.

Reference Ranges

Reference
2.5–7.5mmol/L
2.5
3
6
7.5
LowNormalHigh
Reference
Optimal
Unit · mmol/L

Reference ranges may vary slightly based on laboratory standards and patient demographics.

Overview

Übersicht

Urea, also known as blood urea nitrogen (BUN), is a waste product formed in the liver through the urea cycle, where ammonia is converted into urea. This process is crucial for the detoxification of ammonia, a byproduct of protein metabolism. Urea is then transported in the blood to the kidneys, where it is excreted in urine. Researchers have long used BUN as a marker for assessing renal function, as it reflects the kidney's ability to filter waste products from the blood. Elevated BUN levels can indicate impaired kidney function or other conditions affecting the urea cycle. Clinically, BUN is an important marker for diagnosing and monitoring renal diseases, such as acute kidney injury and chronic kidney disease. It is also used to evaluate the severity of conditions like severe acute pancreatitis, where elevated levels may predict complications and mortality. In the context of athletic performance and biohacking, BUN levels can provide insights into protein metabolism and hydration status. Athletes and biohackers may monitor BUN to optimize protein intake and kidney health. However, BUN levels can be influenced by factors such as diet, hydration, and muscle mass, which may confound results. Therefore, it is important to consider these factors when interpreting BUN levels, and fasting or standardized testing conditions may be recommended to reduce variability.

Klinische Bedeutung

Elevated BUN levels may indicate renal dysfunction, dehydration, or increased protein catabolism. Low BUN levels can suggest liver dysfunction or malnutrition.

Dynamics

Trend Interpretation

Rising Values

Progressively rising BUN levels suggest worsening renal function or dehydration. Retest in 4 weeks if levels are outside the optimal range.

Falling Values

Progressively falling BUN levels may indicate improved hydration or dietary changes.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Renal dysfunction
  • Dehydration
  • High protein diet
  • Heart failure
  • Gastrointestinal bleeding
Cause

Low Levels

  • Liver failure
  • Malnutrition
  • Overhydration
  • Low protein diet
  • Pregnancy
Protocol

How to Optimize

Lever

Lifestyle

  • Maintain adequate hydration
  • Regular exercise
  • Monitor protein intake
Lever

Nutrition

  • Balanced protein consumption
  • Increase water intake
  • Limit excessive protein supplements

Note:

Consult a healthcare provider before making significant dietary or lifestyle changes, especially if kidney function is impaired.

Testing Guidelines

✓Fasting Not Required
✓Not Time-Sensitive

BUN levels can vary throughout the day; testing at the same time is recommended for consistency.

Testing Frequency

Annually for healthy adults, more frequently if monitoring kidney function.

Interfering Factors

  • High protein intake
  • Dehydration
  • Recent intense exercise

Related Peptides & Hormones

Creatinine

Correlated with

hormone or peptide

Open Research Questions

Current research suggests that reference ranges and optimal targets for blood urea nitrogen (BUN) remain debated, particularly in the context of acute kidney injury and severe acute pancreatitis, where confounding factors may affect its predictive value. Emerging research directions include the identification of novel urinary biomarkers for renal injury and the development of non-invasive ammonia detection methods. However, clinical questions regarding the sensitivity and specificity of these biomarkers in diverse populations remain unanswered.

53 Research Publications

693

Total Citations

29

Human/RCT

2.6

Avg. Influence

2026

Latest

Sort
Filter
#01

Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure.

ReviewInfluence8.0
223
This study highlighted blood urea nitrogen (BUN) as a potential biomarker for neurohormonal activation in heart failure. Researchers noted that BUN levels could indicate renal response to neurohormonal changes, suggesting its relevance in heart failure management.
View on PubMed
#02

Curcumin ameliorates cadmium-induced nephrotoxicity in Sprague-Dawley rats.

AnimalInfluence4.0
103
View on PubMed
#03

Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study.

HumanInfluence3.0
83
Researchers observed that vancomycin combined with piperacillin-tazobactam increased creatinine levels but did not significantly affect blood urea nitrogen (BUN) or other kidney biomarkers. This suggests that changes in creatinine may represent pseudotoxicity rather than true kidney injury.
View on PubMed
#04

Blood urea nitrogen and creatinine.

HumanInfluence5.0
68
This study examined the relationship between serum creatinine and blood urea nitrogen (BUN) levels in assessing kidney function. Researchers found that while both markers are useful, serum creatinine is less influenced by external factors and provides a more accurate evaluation of renal health.
View on PubMed
#05

Identification of Novel Biomarker for Early Detection of Diabetic Nephropathy.

UnknownInfluence2.0
36
Researchers found that diabetic nephropathy (DN) in rats was associated with increased blood urea nitrogen (BUN) and serum creatinine levels, indicating kidney injury. The study identified novel biomarkers that could aid in the early detection of DN.
View on PubMed
#06

Renal changes and acute kidney injury in covid-19: a systematic review.

Review
34
Researchers conducted a systematic review on renal changes in COVID-19 patients. The review found that increased blood urea nitrogen (BUN) levels were common in patients with acute kidney injury (AKI), indicating significant renal impact from the virus.
View on PubMed
#07

Blood Urea Nitrogen as a Prognostic Marker in Severe Acute Pancreatitis.

HumanInfluence2.0
20
Researchers found that blood urea nitrogen (BUN) levels were significantly higher in patients with severe acute pancreatitis who did not survive compared to those who did. The study indicated that BUN could serve as an independent risk factor for mortality, with a specific cutoff value predicting 30-day all-cause mortality.
View on PubMed
#08

Blood Urea Nitrogen/Albumin Ratio and Mortality Risk in Patients with COVID-19.

HumanInfluence1.0
20
This study explored the relationship between blood urea nitrogen (BUN), albumin, and mortality risk in COVID-19 patients. Researchers found that elevated BUN levels were associated with increased in-hospital mortality, suggesting BUN could be a reliable predictor of clinical outcomes in COVID-19 cases.
View on PubMed
#09

A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease.

ReviewInfluence2.0
17
Researchers reviewed laboratory biomarkers for predicting severe COVID-19 disease. They highlighted that blood urea nitrogen (BUN) levels are important indicators of kidney function and disease severity in COVID-19 patients.
View on PubMed
#10

Training Load Measures and Biomarker Responses during a 7-Day Training Camp in Young Cyclists-A Pilot Study.

Human
13
View on PubMed

Clinical Trials (4)

4

Total Trials

668

Total Enrolled

A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders

NCT06904027RECRUITING
Sponsor

Tongji Hospital

Enrollment

40

Started

2025

Primary outcome

Mean blood ammonia levels at month 3 after enrollment.

Urea Cycle Disorders

Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )

NCT04750707Phase 3COMPLETED
Sponsor

Global Health Uganda LTD

Enrollment

270

Started

2021

Primary outcome

The frequency, age specific prevalence and severity of Sickle Cell Vasculopathy manifested by New stroke as assessed by the Pediatric NIH Stroke Scale (PedNIHSS) over the 3-year study while on hydroxyurea treatment, compared to baseline assessments.

Sickle Cell Anemia in Children

BUN/Cr-based Hydration Therapy to Improve Outcome of Patients With Acute Ischemic Stroke

NCT05121389Phase 3UNKNOWN
Sponsor

Chang Gung Memorial Hospital

Enrollment

288

Started

2021

Primary outcome

The rate of early neurological improvement at 72 hours after the onset of stroke

DehydrationIschemic Stroke

Novel Dose Escalation to Predict Treatment With Hydroxyurea

NCT02042222Early Phase 1COMPLETED
Sponsor

Baylor College of Medicine

Enrollment

70

Started

2013

Primary outcome

Time to patients reaching the maximum tolerated dose (MTD) of the medication

Sickle Cell Disease

Publication Trend

Research publications about Harnstoff over time

8total
1
'14
1
'18
1
'20
2
'21
1
'22
2
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer